AHA Scientific Sessions 2025 Abstract
VANQUISH-2: Phase 3, Randomized, Double-blind, Placebo-controlled, Trial of weekly subcutaneous administration of VK2735 in Obese or Overweight Adults with Type 2 Diabetes
Trial in peopleInterventions
Papers by Karen Albers
1 result